Kaija Salmela
Overview
Explore the profile of Kaija Salmela including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
629
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Helantera I, Salmela K, Kyllonen L, Koskinen P, Gronhagen-Riska C, Finne P
Transplantation
. 2014 Mar;
98(4):458-64.
PMID: 24646770
Background: Although longer pretransplant dialysis has been associated with poor kidney transplant outcome, no data about this association exist from the current era or from Europe. We studied the association...
2.
Kaartinen K, Hemmila U, Salmela K, Raisanen-Sokolowski A, Kouri T, Makela S
J Am Soc Nephrol
. 2014 Jan;
25(4):671-4.
PMID: 24459232
Adenine phosphoribosyltransferase deficiency is a rare autosomal recessive disorder manifesting as urolithiasis or crystalline nephropathy. It leads to the generation of large amounts of poorly soluble 2,8-dihydroxyadenine excreted in urine,...
3.
Makela S, Honkanen E, Isoniemi H, Jalanko H, Koskinen P, Kyllonen L, et al.
Duodecim
. 2013 Nov;
129(18):1893-900.
PMID: 24187780
The annual number of kidney transplantations in Finland is 150 to 200. Successful kidney transplantation improves the patient's quality of life and prognosis and is cost-effective as compared with dialytic...
4.
Helantera I, Salmela K, Kyllonen L, Raisanen-Sokolowski A, Auvinen E, Mannonen L, et al.
Clin Transplant
. 2012 Oct;
26(6):E596-601.
PMID: 23083418
The incidence and clinical course of polyomavirus-associated nephropathy (PyVAN) in our well-HLA-matched kidney transplant population mainly on low-dose cyclosporine-based triple-drug immunosuppression has not been described in detail. We aimed to...
5.
Korsgren S, Molin Y, Salmela K, Lundgren T, Melhus A, Korsgren O
Am J Pathol
. 2012 Sep;
181(5):1735-48.
PMID: 22944599
The cause of type 1 diabetes (T1D) remains unknown; however, a decisive role for environmental factors is recognized. The increased incidence of T1D during the last decades, as well as...
6.
Kramer B, Klinger M, Vitko S, Glyda M, Midtvedt K, Stefoni S, et al.
Transplantation
. 2012 Aug;
94(5):492-8.
PMID: 22858806
Background: Long-term use of corticosteroids is associated with considerable morbidity, including cardiovascular and metabolic adverse effects. Methods: This study evaluated the long-term efficacy and safety of two steroid-free regimens compared...
7.
Lempinen M, Halme L, Arola J, Honkanen E, Salmela K, Lautenschlager I
Transpl Int
. 2012 May;
25(7):776-82.
PMID: 22616807
In immunosuppressed patients human herpesvirus 6 (HHV-6) reactivations are common. The aim of the study was to determine to which extent HHV-6 can be found in the gastrointestinal tract in...
8.
Caballero-Corbalan J, Brandhorst H, Malm H, Felldin M, Foss A, Salmela K, et al.
J Surg Res
. 2011 May;
175(1):163-8.
PMID: 21550052
Background: Histidine-tryptophan-ketoglutarate (HTK) has been established as an alternative to University-of-Wisconsin solution (UWS) for abdominal organ preservation, but data about HTK efficiency to preserve pancreata during prolonged cold ischemia time...
9.
Kahu J, Kyllonen L, Raisanen-Sokolowski A, Salmela K
Clin Transplant
. 2011 Feb;
25(3):E276-83.
PMID: 21303414
Different donor parameters and baseline biopsy have been used to assess the quality of donor organs. There is, however, no consensus which risk factors and chronic changes in the donor...
10.
Saha H, Kyllonen L, Koskinen P, Salmela K
Duodecim
. 2010 Dec;
126(22):2591-9.
PMID: 21188875
In the treatment of end-stage renal disease, kidney transplantation is the best and most cost-effective alternative with regard to both prognosis and quality of life. Problems arise from the disproportion...